[引用][C] Cerebrum and cardiac protection with allopurinol
R Stegeman, M Nijman, JMPJ Breur, F Groenendaal… - Neonatal Cardiac Disease, 2022
Management of hypertension addressing hyperuricaemia: introduction of nano-based approaches
K Girigoswami, R Arunkumar, A Girigoswami - Annals of Medicine, 2024 - Taylor & Francis
… XO transforms allopurinol into its primary metabolite, oxypurinol. Allopurinol and oxypurinol
share structural similarities with the purine bases HPX and XAN, respectively ( Figure 2 ). …
share structural similarities with the purine bases HPX and XAN, respectively ( Figure 2 ). …
Pharmacogenomics for primary care: an overview
V Rollinson, R Turner, M Pirmohamed - Genes, 2020 - mdpi.com
… allopurinol-associated SCARs demonstrated that oxypurinol … but allopurinol and febuxostat
did not, indicative of oxypurinol… granulysin in response to oxypurinol likely participate in the …
did not, indicative of oxypurinol… granulysin in response to oxypurinol likely participate in the …
On the clinical pharmacology of reactive oxygen species
Reactive oxygen species (ROS) have been correlated with almost every human disease. Yet
clinical exploitation of these hypotheses by pharmacological modulation of ROS has been …
clinical exploitation of these hypotheses by pharmacological modulation of ROS has been …
CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass …
R Stegeman, M Nijman, JMPJ Breur, F Groenendaal… - Trials, 2022 - Springer
… neonates received allopurinol PFI … pharmacokinetic data of allopurinol, oxypurinol,
hypoxanthine, xanthine, and uric acid and to establish if expected target concentrations of allopurinol …
hypoxanthine, xanthine, and uric acid and to establish if expected target concentrations of allopurinol …
Safety and tolerability of available drugs for hyperuricemia: a critical review and an update on recent developments.
G Fang, W Li, J Zhang, Q Ke, X Zhu… - Journal of Chinese …, 2022 - search.ebscohost.com
… Oxypurinol Oxypurinol is an active metabolite of allopurinol oxidation and has a stronger
inhibitory … Its drug action and curative effect are similar to those of allopurinol, while the adverse …
inhibitory … Its drug action and curative effect are similar to those of allopurinol, while the adverse …
Allopurinol lowers serum urate but does not reduce oxidative stress in CKD
M Sun, N Hines, D Scerbo, J Buchanan, C Wu… - Antioxidants, 2022 - mdpi.com
… The effects of allopurinol and its downstream metabolite, oxypurinol, on pyrimidine synthesis
include inhibition of orotodine monophosphate decarboxylase (OMD) [51]. The inhibition of …
include inhibition of orotodine monophosphate decarboxylase (OMD) [51]. The inhibition of …
What's new on the front-line of gout pharmacotherapy?
KEG Blake, JL Saag, KG Saag - Expert Opinion on …, 2022 - Taylor & Francis
… Allopurinol is metabolized into the active metabolite oxypurinol primarily by the enzyme …
Allopurinol has a half-life of 1.2 hours, whereas oxypurinol’s half-life is 23 hrs. The active …
Allopurinol has a half-life of 1.2 hours, whereas oxypurinol’s half-life is 23 hrs. The active …
Effect of glycation of bovine serum albumin on the interaction with xanthine oxidase inhibitor allopurinol: Spectroscopic studies and molecular modeling
N Rahman, N Khalil - Journal of Molecular Liquids, 2022 - Elsevier
… The action pathway of allopurinol is to inhibit the functioning … also converts allopurinol to
its active metabolite oxypurinol (… affects the pharmacokinetics and pharmacodynamics of the …
its active metabolite oxypurinol (… affects the pharmacokinetics and pharmacodynamics of the …
Wastewater-based prevalence trends of gout in an Australian community over a period of 8 years
… is metabolised into oxypurinol and … oxypurinol in wastewater. A total of 180 wastewater
samples collected between 2012 and 2019 were analysed for oxypurinol to estimate allopurinol …
samples collected between 2012 and 2019 were analysed for oxypurinol to estimate allopurinol …